1. Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone. Issue 1 (December 2016) Authors: Palmerini, E.; Jones, R.; Marchesi, E.; Paioli, A.; Cesari, M.; Longhi, A.; Meazza, C.; Coccoli, L.; Fagioli, F.; Asaftei, S.; Grignani, G.; Tamburini, A.; Pollack, S.; Picci, P.; Ferrari, S. Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis. (23rd October 2013) Authors: Gironi, M.; Solaro, C.; Meazza, C.; Vaghi, M.; Montagna, L.; Rovaris, M.; Batocchi, A. P.; Nemni, R.; Albertini, R.; Zaffaroni, M.; Bozzola, M. Other Names: Geurts Jeroen Academic Editor. Journal: Multiple sclerosis international Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer. Issue 13 (September 2015) Authors: Terenziani, M.; Massimino, M.; Magazzù, D.; Gandola, L.; Capri, G.; Carcangiu, M.L.; Catania, S.; Di Russo, A.; Gennaro, M.; Meazza, C.; Podda, M.; Schiavello, E.; Valagussa, P. Journal: European journal of cancer Issue: Volume 51:Issue 13(2015:Sep.) Page Start: 1667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. TREATING LYMPHOMA IN THE PANDEMIC ERA: WHAT WE LEARNED FROM OUR EXPERIENCE AT FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI. (October 2022) Authors: Gattuso, G.; Biassoni, V.; Podda, M.; Meazza, C.; Chiaravalli, S.; Nigro, O.; Sironi, G.; Livellara, V.; Puma, N.; Bergamaschi, L.; Terenziani, M.; Spreafico, F.; Massimino, M.; Schiavello, E. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗